ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 225 filers reported holding ICU MED INC in Q3 2017. The put-call ratio across all filers is 6.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $251 | -79.9% | 1,406 | -81.4% | 0.00% | -86.7% |
Q1 2023 | $1,250 | +4.1% | 7,578 | -0.6% | 0.02% | 0.0% |
Q4 2022 | $1,201 | -99.9% | 7,625 | +15.3% | 0.02% | +25.0% |
Q2 2022 | $1,087,000 | -32.1% | 6,615 | -8.0% | 0.01% | 0.0% |
Q1 2022 | $1,601,000 | +36.4% | 7,193 | +45.5% | 0.01% | +100.0% |
Q4 2021 | $1,174,000 | -2.2% | 4,945 | -3.8% | 0.01% | 0.0% |
Q3 2021 | $1,200,000 | +8.7% | 5,143 | -4.1% | 0.01% | +20.0% |
Q2 2021 | $1,104,000 | -26.3% | 5,365 | -26.4% | 0.01% | -37.5% |
Q1 2021 | $1,498,000 | -43.1% | 7,294 | -40.6% | 0.01% | -42.9% |
Q4 2020 | $2,633,000 | +1864.9% | 12,276 | +1572.5% | 0.01% | +1300.0% |
Q3 2020 | $134,000 | -83.5% | 734 | -83.3% | 0.00% | -85.7% |
Q2 2020 | $811,000 | +132.4% | 4,400 | +154.0% | 0.01% | +133.3% |
Q1 2020 | $349,000 | -87.8% | 1,732 | -88.6% | 0.00% | -88.5% |
Q4 2019 | $2,849,000 | +53.8% | 15,224 | +31.2% | 0.03% | +73.3% |
Q3 2019 | $1,852,000 | -46.1% | 11,603 | -14.9% | 0.02% | -37.5% |
Q2 2019 | $3,433,000 | +42.7% | 13,627 | +35.5% | 0.02% | +9.1% |
Q1 2019 | $2,406,000 | -67.1% | 10,055 | -68.5% | 0.02% | -65.6% |
Q4 2018 | $7,323,000 | +843.7% | 31,892 | +1062.7% | 0.06% | +966.7% |
Q3 2018 | $776,000 | -37.5% | 2,743 | -35.1% | 0.01% | -45.5% |
Q2 2018 | $1,242,000 | -56.5% | 4,229 | -62.6% | 0.01% | -52.2% |
Q1 2018 | $2,856,000 | +136.8% | 11,316 | +102.7% | 0.02% | +109.1% |
Q4 2017 | $1,206,000 | -11.2% | 5,582 | -23.6% | 0.01% | -8.3% |
Q3 2017 | $1,358,000 | +232.0% | 7,306 | +207.9% | 0.01% | +200.0% |
Q2 2017 | $409,000 | +255.7% | 2,373 | +215.1% | 0.00% | +300.0% |
Q1 2017 | $115,000 | -97.3% | 753 | -97.4% | 0.00% | -97.1% |
Q4 2016 | $4,218,000 | +9.1% | 28,627 | -6.4% | 0.04% | -14.6% |
Q3 2016 | $3,865,000 | +26.0% | 30,586 | +12.4% | 0.04% | +86.4% |
Q2 2016 | $3,068,000 | +3.7% | 27,209 | -4.3% | 0.02% | +4.8% |
Q1 2016 | $2,959,000 | +927.4% | 28,424 | +707.7% | 0.02% | +2000.0% |
Q4 2014 | $288,000 | -86.9% | 3,519 | -89.1% | 0.00% | -88.9% |
Q3 2013 | $2,197,000 | +1715.7% | 32,343 | +1824.0% | 0.01% | +800.0% |
Q2 2013 | $121,000 | – | 1,681 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nitorum Capital, L.P. | 460,038 | $92,822,000 | 7.19% |
NUANCE INVESTMENTS, LLC | 526,008 | $106,133,000 | 3.68% |
PFM Health Sciences, LP | 202,339 | $40,826,000 | 3.35% |
CROWN ADVISORS MANAGEMENT, INC. | 20,000 | $4,035,000 | 3.19% |
PURA VIDA INVESTMENTS, LLC | 126,784 | $25,581,000 | 3.04% |
Sandhill Capital Partners LLC | 107,817 | $21,754,000 | 2.92% |
PURA VIDA INVESTMENTS, LLC | 121,500 | $24,515,000 | 2.91% |
KIRR MARBACH & CO LLC /IN/ | 24,126 | $4,868,000 | 2.08% |
Penn Capital Management Company, LLC | 44,620 | $9,053,000 | 1.49% |
GW&K Investment Management, LLC | 351,543 | $70,930,000 | 1.25% |